Slotnik Capital, LLC / APLSUSD
Slotnik Capital, LLC’s Apellis Pharmaceuticals Inc Position
Does Slotnik Capital, LLC own Apellis Pharmaceuticals Inc (APLSUSD)? Yes — 135.0K shares worth $5M (+1.59% of its 13F portfolio) as of Q1 2026.
Position Value
$5M
Q1 2026
Shares
135.0K
% of Portfolio
+1.59%
Quarters Held
1
currently held
Position History APLSUSD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 135.0K | $5M | +1.59% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Slotnik Capital, LLC’s full portfolio or all institutional holders of APLSUSD.